EPHA2 and glioblastoma: Accordingly, antibody (against glioblastoma stem cells surface markers glycoprotein cluster of differentiation 44 (CD44) and ephrin receptor A2 (EPHA2)-antisense oligodeoxynucleotides (ASOs) strategy against FAM107A) were established for the treatment of GBM [154].